Results 11 to 20 of about 11,794,809 (149)

Management of Large Cell Neuroendocrine Carcinoma [PDF]

open access: yesFrontiers in Oncology, 2021
BackgroundLarge cell neuroendocrine carcinoma (LCNEC) is a rare, aggressive cancer with a dismal prognosis. The majority of cases occur in the lung and the gastrointestinal tract; however, it can occur throughout the body.
Virginia Corbett   +3 more
doaj   +2 more sources

Pulmonary Combined Large Cell Neuroendocrine Carcinoma [PDF]

open access: yesPathology and Oncology Research, 2022
Pulmonary combined large-cell neuroendocrine carcinoma (CLCNEC) is a rare neuroendocrine tumor pertained to lung large cell neuroendocrine carcinoma (LCNEC) with aggressive behavior and poor prognosis generally.
Meihui Li   +9 more
doaj   +2 more sources

Large Cell Neuroendocrine Carcinoma of Gallbladder: A Case Report

open access: yesJournal of Nepal Medical Association
Large cell neuroendocrine carcinoma of the gallbladder is an extremely rare tumour with aggressive behaviour and a bad prognosis. Here, we report a case of a 65-year-old lady suspected of carcinoma of the gallbladder and underwent extended ...
Dhruba Narayan Sah, Oshan Shrestha
doaj   +2 more sources

Large cell neuroendocrine carcinoma of the kidney with cardiac metastasis: a case report [PDF]

open access: yesJournal of Medical Case Reports, 2017
Background Primary large cell neuroendocrine carcinoma of the kidney is a rare and generally very aggressive disease. We present a case of a patient with primary large cell neuroendocrine carcinoma of the kidney with cardiac metastasis. Case presentation
Moeka Shimbori   +9 more
doaj   +2 more sources

Mixed Small Cell and Large Cell Neuroendocrine Carcinoma of the Endometrium

open access: yesPhilippine Journal of Pathology, 2021
Neuroendocrine carcinoma (NEC) of the endometrium is a rare, aggressive subtype of endometrial cancer.  We report a 61-year-old female with a history of breast cancer, s/p modified radical mastectomy, chemotherapy, radiotherapy and hormonal (tamoxifen ...
Joshua Uyboco   +5 more
doaj   +2 more sources

Large cell neuroendocrine carcinoma (LCNEC) of the urinary bladder: a case report

open access: yesDiagnostic Pathology, 2013
Neuroendocrine carcinoma of the urinary bladder is a rare entity, accounting less then 1% of urinary bladder malignancies. The vast majority of the neuroendocrine carcinoma of the urinary bladder is represented by small cell neuroendocrine carcinoma ...
Colarossi Cristina   +6 more
doaj   +2 more sources

Large Cell Neuroendocrine Carcinoma of the Uterine Cervix Associated with Adenocarcinoma [PDF]

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2007
Objective: Large cell neuroendocrine carcinoma (LCNEC) is a rare and aggressive cervical neoplasm. In the present study, we present a 45-year-old woman with large cell neuroendocrine uterine cervical carcinoma with coexisting adenocarcinoma. Case Report:
Ma-Lee Ko   +5 more
doaj   +2 more sources

Expression studies on PPARγ in pancreatic neuroendocrine tumours [PDF]

open access: yes, 2010
MDPancreatic NETs occur with an annual incidence of around 5 per 1,000,000 population per year, with survival rates of between 30 – 97% at 5 years depending on the tumour subtype.
Hanson, Matthew Richard
core   +4 more sources

Large-cell neuroendocrine tumor of the prostate: a case report and review of the literature

open access: yesJournal of Medical Case Reports, 2021
Background Primitive neuroendocrine prostate neoplasms are rarely reported. This entity comprises carcinoïd tumors and poorly differentiated neuroendocrine tumors, mainly those of the small-cell type. Large-cell-type primitive tumors are exceptional, and
Walid Sleiman   +9 more
doaj   +1 more source

THE PROGNOSIS OF THE DIFFERENT ESOPHAGEAL NEUROENDOCRINE CARCINOMA SUBTYPES: A POPULATION-BASED STUDY

open access: yesArquivos de Gastroenterologia, 2022
Background Neuroendocrine neoplasms are extremely rare and account for 0.4% to 2% of all malignant esophageal neoplasms. The burden of the neuroendocrine histological type on the patients’ prognosis and survival is poorly debated.
Francisco TUSTUMI   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy